A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.


Updates from The Motley Fool

Latest updates on Celsion from Fool.com.


Stock Performance

CLSN vs. S&P 500 | 2 Year Performance
View Interactive CLSN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Celsion.
Current Price: $1.24
Prev Close: $1.26
Open: $1.27
Bid: $1.19
Ask: $1.35
Day's Range: $1.22 - $1.28
52wk Range: $1.04 - $2.31
Volume: 63,754
Avg Vol 132,383
Market Cap: $28.81M
P/E (ttm): -1.50
EPS (ttm): -$0.84
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Celsion.
CAPS Rating 1 out of 5
 
80 Outperform
19 Underperform
CAPS All Stars
 
7 Outperform
11 Underperform

How do you think Celsion will perform against the market?



You pick for Celsion is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Celsion.

A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers